Marc Hurlbert, PhD
The Melanoma Research Alliance (MRA) recently appointed Marc Hurlbert, PhD, as the organization’s Chief Science Officer. Dr. Hurlbert will succeed Louise Perkins, PhD, who will retire form the role after serving MRA for more than 5 years.
As Chief Science Officer, Dr. Hurlbert will guide MRA’s scientific strategy as well as oversee the organization’s peer-reviewed grant-making program and scientific collaborations. He comes to MRA after having spent more than 10 years in breast cancer research. ■